Clinical Trials Sponsored by Global Institute for Hispanic Health

Total 3014 results

Texas A&M University
Driscoll Children's Hospital; Global Institute for Hispanic Health

Recruiting

Impact of a Mobile App on Pregnant Women's Prenatal Genetic Testing Decision-making

Pregnant Women | Mobile Applications | Prenatal Care | Genetic Testing

United States
Barcelona Institute for Global Health

Completed

Pregnant Women for Malaria Surveillance (MiPMon)

P. Falciparum
Barcelona Institute for Global Health

Not yet recruiting

A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)

Infectious Disease | Child, Only | Febrile Illness
Barcelona Institute for Global Health

Not yet recruiting

L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)

Infections | Infectious Disease | Child, Only
Barcelona Institute for Global Health

Completed

Maternal Diet, Body Mass Index Trajectories and Cardiometabolic Risk in Early Childhood

Growth | Childhood Obesity | Cardiometabolic Risk
Barcelona Institute for Global Health

Completed

Fatty Acids and Attention Deficit and Hyperactivity Disorder Symptoms

Attention Deficit Hyperactivity Disorder | Child Behavior Problem | Fatty Acid Deficiency
Barcelona Institute for Global Health

Completed

PHENOTYPE. Therapeutic Study in Barcelona

Poor Mental Health | Natural Outdoor Environments
Barcelona Institute for Global Health
UNITAID

Active, not recruiting

Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) (BOHEMIA)

Malaria

Mozambique, Kenya
Jhpiego
Barcelona Institute for Global Health

Completed

TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance Study (TIPTOP-DRS)

Malaria in Pregnancy

Congo, The Democratic Republic of the, Madagascar, Mozambique, Nigeria
Jhpiego
Barcelona Institute for Global Health

Completed

Evaluating the Effects of Community Delivery of Malaria Intermittent Preventive Treatment on Pregnant Women and Babies (TIPTOP)

Malaria in Pregnancy

Congo, The Democratic Republic of the, Madagascar, Mozambique, Nigeria
Barcelona Institute for Global Health
Carlos III Health Institute

Completed

Walnuts, Long-Chain Polyunsaturated Fatty Acids and Adolescent Brain Development (WALNUTs)

Neurobehavioral Manifestations | Vitamin/Nutritional Deficiency

Spain
The George Institute for Global Health, Australia

Completed

Days Alive and Out of Hospital for Patients With Sepsis

Sepsis | Septic Shock

Australia
GSK Vaccines Institute For Global Health S.r.l.

Completed

A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.

Shigellosis

France
Karolinska Institutet
The George Institute for Global Health, India

Not yet recruiting

ATLS vs Standard Care Trial

Wounds and Injuries
The George Institute for Global Health, China

Completed

Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3,CPACS-3 (CPACS-3)

Acute Coronary Syndromes

China
GSK Vaccines Institute For Global Health S.r.l.

Completed

Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults

Shigellosis

United Kingdom
The George Institute for Global Health, Australia

Completed

The Fluid Translation of Research Into Practice Study (Fluid-TRIPS)

Critical Care, Fluid Resuscitation

Australia
The George Institute for Global Health, China

Completed

Activating Media for Salt Reduction

Hypertensive Disease

China
The George Institute for Global Health, China

Completed

Rehabilitation for Disabled Stroke Patients in Rural China (RECOVER)

Stroke

China
The George Institute for Global Health, China

Completed

China Rural Health Initiative Follow up Study (CRHIFU)

Cardiovascular Disease

China
Medicines Development for Global Health

Completed

A Pharmacokinetic and Safety Study of Moxidectin to Identify an Optimal Dose for Treatment of Children 4 to 11 Years

Onchocerciasis

Ghana
Medicines Development for Global Health

Completed

Dose-finding Study of Moxidectin for Treatment of Scabies

Scabies

Australia, Austria, France
Medicines Development for Global Health

Active, not recruiting

Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis

Onchocerciasis

Congo, The Democratic Republic of the
Medicines Development for Global Health

Recruiting

Efficacy and Safety Study of Moxidectin in Adults With Scabies

Scabies

United States, Honduras
Medicines Development for Global Health

Recruiting

Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole

Onchocerciasis

Côte D'Ivoire, Congo, The Democratic Republic of the
Medicines Development for Global Health

Completed

Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers

QT Effects in Healthy Volunteers

United States
Beijing Anzhen Hospital
The George Institute for Global Health, Australia; The George Institute for... and other collaborators

Recruiting

Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation (PROMPT-AF)

Persistent Atrial Fibrillation | Catheter Ablation

China
Beijing Anzhen Hospital
The George Institute for Global Health, Australia; The George Institute for... and other collaborators

Recruiting

Cardiovascular Risk Reduction in Atrial Fibrillation Trial (CRAFT)

Hypertension | Atrial Fibrillation

China
The George Institute for Global Health, China
Changhai Hospital

Recruiting

Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy Trial (LATE-MT)

Acute Ischemic Stroke

China
The George Institute for Global Health, China
Changhai Hospital

Terminated

Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2) (ENCHANTED2)

Acute Ischemic Stroke

China
Universidad Peruana Cayetano Heredia
Barcelona Institute for Global Health

Completed

Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 (SAINT-PERU)

Coronavirus Infection | Covid19 | SARS-CoV Infection

Peru
Duke University
The George Institute for Global Health, China

Completed

Weight Loss Among Adults in Beijing, China

Hypertension | Obesity

China
Region Skane
The George Institute for Global Health, Australia

Not yet recruiting

International Care Bundle Evaluation in Cerebral Hemorrhage Research (I-CATCHER)

Stroke | Intraventricular Hemorrhage | Cerebrovascular Disease | Intracerebral Hemorrhage | Intracerebral Haemorrhage

Australia, Sweden
Medicines Development for Global Health
World Health Organization

Completed

Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection

Onchocerciasis

Ghana
Medicines Development for Global Health
World Health Organization

Completed

Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection

Onchocerciasis

Congo, The Democratic Republic of the, Ghana, Liberia
Craig Anderson
Johns Hopkins University; Genentech, Inc.; The George Institute for Global Health...

Recruiting

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

Acute Ischemic Stroke Patients Receiving Reperfusion Therapy

Australia, United Kingdom, United States, Chile, China, Malaysia, Mexico
Hospital Universitari Vall d'Hebron Research Institute
Barcelona Institute for Global Health

Completed

Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR) (CATCOVID-AIR)

Covid19 | Corona Virus Infection | Acute Respiratory Failure

Spain
University of Sydney
The George Institute for Global Health, India

Terminated

Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19 (CLARITY 2)

COVID-19 | SARS-CoV2 Infection

India
The George Institute for Global Health, China
National Health and Medical Research Council, Australia; Global Alliance for...

Completed

SMARTHealth Diabetes in China Using Lay Family Health Promoters

Hypertension | Diabetes Mellitus, Type 2 | Dyslipidemias

China
The George Institute for Global Health, China
Ningxia Medical University

Completed

NUTS for the Prevention of Cardiovascular Disease in Chinese Adults (NUTS)

Cardiovascular Diseases | Dyslipidemias

China
The George Institute for Global Health, China
Chinese Diabetes Society

Completed

Observational Registry for Basal Insulin Treatment Study (ORBIT)

Diabetes

China
University of Calgary
The George Institute for Global Health, Australia

Not yet recruiting

ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 (ACT-WHEN)

Acute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke Acute

Canada, Australia
The George Institute for Global Health, China
National Heart, Lung, and Blood Institute (NHLBI)

Completed

High Cardiovascular Risk Management and Salt Reduction in Rural Villages in China

Cardiovascular Disease

China
Seattle Institute for Biomedical and Clinical Research
Puget Sound Partners for Global Health

Completed

Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder: A Pilot Study (MBSRforPTSD)

Depression | Stress Disorders, Post-Traumatic

United States
Centre for Global eHealth Innovation
University Health Network, Toronto; Trillium Health Partners

Unknown

Adoption, Acceptability, and Effectiveness of a Mobile Health App for Personalised Prostate Cancer Survivorship Care.

Prostate Cancer

Canada
Janssen Research & Development, LLC
The George Institute for Global Health, Australia

Completed

A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus (CANVAS-R)

Diabetes Mellitus, Type 2 | Albuminuria

Australia, France, Italy, Poland, Ukraine, United Kingdom, United States, China, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Malaysia, Canada, Netherlands, Korea, Republic of, New Zealand, Brazil, Russian Federation, Puerto... and more
Unity Health Toronto
Canadian Institutes of Health Research (CIHR); The George Institute for Global...

Completed

Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis (SAFE-D)

Atrial Fibrillation | End Stage Renal Failure on Dialysis

Canada, Australia
NICHD Global Network for Women's and Children's...

Recruiting

Maternal Newborn Health Registry (MNH)

Pregnancy Outcome Trends in Low-resource Geographic Areas

United States, Pakistan, Zambia, Congo, The Democratic Republic of the, Guatemala, India, Bangladesh
National Center for Global Health and Medicine,...

Active, not recruiting

Risk Stratification of COVID-19 Using Urine Biomarkers

Covid19 | Urine | Acute Respiratory Failure With Hypoxia | Biomarker

United States, Brazil, Denmark, Japan, Philippines
National Center for Global Health and Medicine,...

Unknown

Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients

HIV Infection | Renal Function Disorder | Renal Tubular Disorder

Clinical Trials Sponsored by Global Institute for Hispanic Health

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations